<DOC>
	<DOCNO>NCT00568282</DOCNO>
	<brief_summary>The primary aim study determine whether identify human lung cancer tumor cell peripheral blood lung cancer patient .</brief_summary>
	<brief_title>Identification Circulating Tumor Cells Peripheral Blood Lung Cancer Patients</brief_title>
	<detailed_description>The purpose study determine whether identify lung cancer cell circulate peripheral blood lung cancer patient use cell surface marker find cancer cell CD44 epithelial specific antigen .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Neoplastic Cells , Circulating</mesh_term>
	<criteria>Inclusion Criteria ( Cases ) : 1 . Advanced stage ( IIIB malignant effusion IV ) histologically cytologically confirm NSCLC 2 . Patients must newly diagnose ( untreated ) evidence disease progression time sample collection 3. ability sign inform consent 4. least 18 year age Inclusion Criteria ( Controls ) : 1. know prior active malignancy 2. ability sign inform consent 3. least 18 year age 1. history cancer nonmelanoma skin cancer within last 5 year 1. history cancer nonmelanoma skin cancer within last 5 year 2. pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>